Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis - Sandborn, W J; Korzenik, J; Lashner, B (Gastroenterology, 2010)
, 1296 e1-3